FindTrial
Sign In

Risk Factors Analysis for Postoperative Survival of Patients with Benign End-stage Lung Diseases Treated by Lung Transplantation

Risk Factors Analysis for Postoperative Survival of Patients with Benign End-stage Lung Diseases Treated by Lung Transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100044727
Enrollment
Unknown
Registered
2021-03-26
Start date
2017-05-01
Completion date
Unknown
Last updated
2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign end-stage lung diseases

Interventions

case series:Nil

Sponsors

Wuxi People's Hospital Affiliated to Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with benign end-stage lung disease were discharged from our hospital after lung transplantation From May 2017 to October 2018.

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

MeasureTime frame
complications;cause of death;—

Countries

China

Contacts

Public ContactXu Hongyang

Wuxi People's Hospital Affiliated to Nanjing Medical University

940216583@qq.com+86 13706180910

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026